AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
7min chapter
Zuckerberg Says Meta to Spend Up to $65 Billion on AI This Year
Bloomberg Businessweek
Navigating the GLP-1 Drug Landscape
This chapter analyzes the competitive dynamics of GLP-1 drugs, focusing on Novo's new drug Amacretin amidst concerns from its previous treatment, Cagrasemma. It explores the substantial market potential for weight-loss medications and the disparities in insurance coverage based on their prescription use. The discussion also delves into the health policy implications and the intricate relationship between pharmaceutical strategies, political influences, and public health outcomes.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode